Home
About YESING
Company Profile
Company Business
International Business
R&D
Production
Delivery
Agent
Products
Medical Consumables
Medical Equipment
Medical Device
Reagent
Non Medical Devices
Solution
High-end medical consumable manufacturing
Smart Healthcare Device Integration Solution
End-to-End Diagnostic Reagent Solutions
Medical Gas Solutions
Blog
Industry Trends
Company News
Contact Us
Inquiry
Chinese
English
French
Russian
Japanese
Immunopathology and Immunotherapy of Type 1 Diabetes
2023-01-10
Type 1 diabetes (T1D) is a complex autoimmune disease mediated by T cells, leading to the destruction of pancreatic beta cells and insufficient insulin secretion.
Top 100 Innovative Medical Device Companies of 2022
2023-01-07
As an emerging industry closely linked to human life and health, the medical device industry has always held significant strategic importance.
Warmly celebrate the successful launch of the website for YESING (Xiamen) Biotechnology Co., Ltd.
2023-01-06
Since its establishment, YESING has been committed to the cause of human health, providing humane, professional, and large-scale medical products and services.
Domestic extracorporeal membrane oxygenation (ECMO) products have been approved for market launch.
2023-01-04
In response to epidemic prevention and control requirements and to ensure the treatment needs of critically ill patients with novel coronavirus pneumonia, on January 4, 2023, the National Medical Products Administration, after review, approved the registration application for an extracorporeal cardiopulmonary support assistive device submitted by Shenzhen Hanuo Medical Technology Co., Ltd.
Scientists have developed a new mathematical model for Alzheimer’s disease.
2022-12-08
Scientists have used a mathematical model to reveal how toxic proteins associated with early-stage Alzheimer’s disease accumulate in the brain. Researchers say this discovery could have significant implications for future treatments.
Scale Expansion and Structural Adjustment! What are the development trends in China’s blood products industry?
2022-11-09
The blood products industry originated in the 1940s. After decades of development, it has become a highly significant segment within the biopharmaceutical industry, characterized by stringent regulatory requirements, high product added value, and oligopolistic competition.